Anxiety
Conditions
Keywords
Guided self help, Cognitive Analytic Therapy, Cognitive Behavioral Therapy
Brief summary
Supporting patients in exerting choice over their treatment is a central aspect of modern healthcare. In Improving Access to Psychological Therapies (IAPT) services, then patients treated at step 2 are only and always offered cognitive-behaviourally informed guided self-help (GSH), when they are deemed suitable for treatment at step 2 of IAPT services (termed CBT-GSH). Step 2 interventions are guided self-help (GSH) delivered by Psychological Wellbeing Practitioners (PWPs). Recently, a new type of GSH has been developed and found to be feasible and effective in IAPT services - this is called cognitive-analytic guided self-help (CAT-GSH). This research aims to test the efficacy of CAT-GSH by comparing outcomes over time achieved in both types of GSH and interviewing participants about their experience of the GSH. The methodology to support patient choice is a patient preference trial. In this method, then patients that meet inclusion criteria for the trial are offered and choose between either CAT-GSH and CBT-GSH. Those patients that are unconcerned with the type of treatment are randomised to either CAT-GSH or CBT-GSH. The primary outcome measure is the Beck Anxiety Inventory. No changes to the standard practice of the PWPs will occur during the trial, the trial will be situated in a standard IAPT service and be a therefore conducted in a routine practice setting.
Interventions
OTHERCognitive Behavioural Therapy Guided Self Help
6-week manualised Cognitive Behavioural Therapy Guided Self Help
OTHERCognitive Analytic Therapy Guided Self Help
6-week manualised Cognitive Analytic Therapy Guided Self Help
Sponsors
University of Sheffield
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Intervention model description
Patient Preference Trial
Eligibility
Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
Yes
Inclusion criteria
* patients have self-referred or been referred by their GP or other health or social care professional for a step 2 intervention for treatment of a common mental health problem, * patients meet criteria for an anxiety disorder on MINI screening interview assessment and also met caseness on the BAI (as defined by a score of \>10 on the BAI at assessment). * Patients want to engage in GSH to address the anxiety disorder * patients are motivated to engage in treatment and can attend six sessions of face-to-face GSH.
Exclusion criteria
* engaging in any another IAPT step 2 interventions. * Do not meet criteria for an anxiety disorder as defined by the MINI and the BAI score. * Meet criteria for depression and a comorbid anxiety disorder, as identified by the BAI and MINI, where the depression is more severe and is the patient's main concern. * Have a severe/chronic mental health problem and are already involved in psychiatric or secondary care mental health services. * Have substance misuse issues that would interfere with engagement with the GSH. * Have a diagnosed learning disability that precludes engagement in GSH. * Have a diagnosis of social phobia or PTSD
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Beck Anxiety Inventory | Measured at screening, at 6 weeks, 12 weeks and 24 weeks | measuring change in anxiety at four time points |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Generalised Anxiety Disorder - 7 | Measured at screening, weekly for 6 weeks, then at 12 week and 24 week follow-up | measuring change in anxiety across the intervention and follow-up |
| patient health questionnaire - 9 | Measured at screening, weekly for 6 weeks, then at 12 week and 24 week follow-up | measuring change in depression across the intervention and follow-up |
Countries
United Kingdom
Contacts
Primary ContactSteve Kellett
Backup ContactEmma Beattie-Edwards
Outcome results
None listed